Simon de Lusignan to Treatment Outcome
This is a "connection" page, showing publications Simon de Lusignan has written about Treatment Outcome.
Connection Strength
0.040
-
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 09 04; 398(10303):843-855.
Score: 0.009
-
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021 09; 9(9):1010-1020.
Score: 0.009
-
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk. BMJ Open. 2021 06 18; 11(6):e046799.
Score: 0.009
-
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study. Hypertension. 2021 03 03; 77(3):846-855.
Score: 0.008
-
The association between diabetes, level of glycaemic control and eye infection: Cohort database study. Prim Care Diabetes. 2017 10; 11(5):421-429.
Score: 0.006